Page last updated: 2024-08-24

plerixafor and Wounds and Injuries

plerixafor has been researched along with Wounds and Injuries in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Deng, X; Han, X; Liu, H; Wang, N; Yan, W1
Barbul, A; Busch, JI; Cervoni-Curet, FN; Kavalukas, SL; Niederhuber, JE; Stuelten, CH; Sutton, E; Wakefield, LM; Webster, JD1
Allen, RJ; Haberman, ID; Lin, CD; Nguyen, PD; Saadeh, PB; Schachar, J; Soares, MA; Szpalski, C; Warren, SM1
Chen, A; Cheng, P; Dong, Y; Guo, F; Huang, H; Liu, H; Qin, L; Xu, F; Yang, Q; Zhang, X1
Allen, RJ; Carr, J; Chang, CC; Gupta, SM; Levine, JP; Lin, CD; Saadeh, PB; Tanaka, R; Tepper, OM; Warren, SM1
Bach, HH; Baker, TA; Gamelli, RL; Majetschak, M; Saini, V; Tripathi, A1

Other Studies

6 other study(ies) available for plerixafor and Wounds and Injuries

ArticleYear
CXCR4 antagonist delivery on decellularized skin scaffold facilitates impaired wound healing in diabetic mice by increasing expression of SDF-1 and enhancing migration of CXCR4-positive cells.
    Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society, 2017, Volume: 25, Issue:4

    Topics: Acellular Dermis; Animals; Benzylamines; Cell Movement; Chemokine CXCL12; Cyclams; Diabetes Mellitus, Experimental; Granulation Tissue; Heterocyclic Compounds; Male; Mice; Receptors, CXCR4; Structure-Activity Relationship; Wound Healing; Wounds and Injuries

2017
SDF-1α mediates wound-promoted tumor growth in a syngeneic orthotopic mouse model of breast cancer.
    PloS one, 2013, Volume: 8, Issue:4

    Topics: Analysis of Variance; Animals; Azo Compounds; Benzylamines; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Chemokine CXCL12; Collagen; Cyclams; Enzyme-Linked Immunosorbent Assay; Female; Heterocyclic Compounds; Immunohistochemistry; Mice; Mice, Inbred BALB C; Microarray Analysis; Signal Transduction; Statistics, Nonparametric; Wounds and Injuries

2013
Combination therapy accelerates diabetic wound closure.
    PloS one, 2014, Volume: 9, Issue:3

    Topics: Animals; Becaplermin; Benzylamines; Cyclams; Diabetes Complications; Diabetes Mellitus, Experimental; Disease Models, Animal; Heterocyclic Compounds; Mice; Neovascularization, Physiologic; Proto-Oncogene Proteins c-sis; Skin Ulcer; Stem Cells; Wound Healing; Wounds and Injuries

2014
Inhibition of SDF-1α/CXCR4 Signalling in Subchondral Bone Attenuates Post-Traumatic Osteoarthritis.
    International journal of molecular sciences, 2016, Jun-16, Volume: 17, Issue:6

    Topics: Animals; Benzylamines; Biomarkers; Bone and Bones; Bone Remodeling; Bone Resorption; Cartilage, Articular; Cell Differentiation; Chemokine CXCL12; Cyclams; Disease Models, Animal; Gene Expression; Heterocyclic Compounds; Male; Mice; Osteoarthritis; Osteoclasts; Receptors, CXCR4; Signal Transduction; Wounds and Injuries; X-Ray Microtomography

2016
Decreased circulating progenitor cell number and failed mechanisms of stromal cell-derived factor-1alpha mediated bone marrow mobilization impair diabetic tissue repair.
    Diabetes, 2010, Volume: 59, Issue:8

    Topics: Animals; Benzylamines; Bone Marrow Cells; Cell Count; Chemokine CXCL2; Chemotaxis; Cyclams; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Heterocyclic Compounds; Ischemia; Mice; Mice, Inbred C57BL; Skin; Stem Cells; Surgical Flaps; Wound Healing; Wounds and Injuries

2010
Initial assessment of the role of CXC chemokine receptor 4 after polytrauma.
    Molecular medicine (Cambridge, Mass.), 2012, Sep-25, Volume: 18

    Topics: Animals; Benzylamines; Cyclams; Female; Heterocyclic Compounds; Interleukin-6; Leukocyte Count; Lipopolysaccharides; Male; Protein Binding; Receptors, Cell Surface; Receptors, CXCR4; Sus scrofa; Teichoic Acids; Tumor Necrosis Factor-alpha; Ubiquitin; Wounds and Injuries

2012